Maryland Heights-based Sentio BioSciences developed a new drug, Zycosan, that in December received approval from the U.S. Food and Drug Administration. Zycosan is designed to control clinical signs associated with osteoarthritis in horses.
Maryland Heights-based Sentio BioSciences developed a new drug, Zycosan, that in December received approval from the U.S. Food and Drug Administration. Zycosan is designed to control clinical signs associated with osteoarthritis in horses.
